Targeted Therapy
Additionally effective in treating gastric cancer is targeted therapy. The targeted therapy targets the mutation in the gene responsible for frequent replication. This intervention method is more accurate than chemotherapy. The physician conducts numerous tests to identify gene mutations and protein components responsible for frequent replication.
There are two categories of targeted therapies:
Angiogenesis inhibitor therapy: Tumors and malignant cells replicate rapidly, necessitating a greater blood supply to sustain their proliferation. Angiogenesis refers to the development of new blood vessels. In order to control tumor growth, new blood vessel growth is inhibited in order to cut off the cancer cells’ nutrient supply. This prevents the growth of the tumor and its invasion of other organs.
The cancer cells generate an excessive amount of protein, which stimulates their replication. Anti-HER2 therapies are used to inhibit the production of these proteins by cancer cells.
Targeted therapy does have some adverse effects, including:
stomach pain
elevated blood pressure
Symptoms of diarrhea
